Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Cellares Lands $255M Series C

2023-08-23
SOUTH SAN FRANCISCO, CA, Cellares, dedicated to clinical and industrial-scale cell therapy manufacturing, announced a $255 million Series C funding round.
Cellares, dedicated to clinical and industrial-scale cell therapy manufacturing, announced a $255 million Series C funding round led by Koch Disruptive Technologies, with participation from Bristol Myers Squibb, DFJ Growth, Willett Advisors, Eclipse, Decheng Capital, and 8VC.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors